Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Fluocinolone Acetonide Intravitreal Implant

Fluocinolone intravitreal implant is produced by EyePoint, a US company. It is indicated for the treatment of chronic non-infectious uveitis involving the posterior segment of the eye. It has the characteristics of local administration to the fundus and continuous and stable drug release for up to 36 months. It can reduce disease recurrence, reduce the side effects of traditional treatments and increase medication compliance.

Brand: injection Categories:

Share: